Packaging & Labelling
FedEx Delivers Relief Shipment to U.S. in fight against COVID-19
Amid the global COVID-19 pandemic, FedEx Express, a subsidiary of FedEx Corp. and the world’s largest express transportation company, has been working with nonprofit organizations around the world to deliver much needed essential aid in the form of medical...
Press Releases
Virpax Pharmaceuticals Partners with MedPharm for Successful Completion of Pre-IND Meeting with FDA on Epoladerm
Virpax Pharmaceuticals Inc., a company specializing in developing pharmaceutical products for pain management by using new drug delivery systems, has announced that it had successfully completed a pre-Investigational New Drug (IND) Application meeting with the U.S. FDA for Epoladerm...
Press Releases
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organisations to make the University of Oxford’s vaccine widely accessible around the world in an equitable manner.
The Company...
Clinical Trials
Abivax gets approval to conduct Covid-19 trial in France
Biotechnology company Abivax has secured approval from France’s National Agency for the Safety of Medicines (ANSM) and French Ethics Committee (CPP) to conduct a Phase IIb/III clinical trial of ABX464 in Covid-19 patients.
The miR-AGE trial will assess the drug...
IT & Data Management
Indica Labs and Octo launch COVID digital pathology repository to support the fight against COVID-19
Indica Labs, a leading provider of computational pathology software, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased to announce the online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution...
Press Releases
Roche’s Tecentriq receives US FDA approval for first-line monotherapy for certain people with metastatic NSCLC
Roche announced that the US FDA has approved Tecentriq® (atezolizumab) as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumours have high PD-L1 expression (PD-L1 stained ≥ 50% of tumour cells or...
Press Releases
Covis Pharma begins phase 3 study of asthma drug, Alvesco to treat COVID-19
Covis Pharma announced the initiation of a phase 3 clinical study to assess the safety and efficacy of its asthma drug Alvesco (ciclesonide) in non-hospitalized patients 12 years of age and older with symptomatic COVID-19. Patient recruitment for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.